Skip to content
healthcare.dev

EvexiTHROID

NDC 73352-695, LEVOTHYROXINE and LIOTHYRONINE, tablet, from Trifluent Pharma, LLC.

Product NDC
73352-695
Status
Listed
Labeler
Trifluent Pharma, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73352-695 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE28.5 ug/1
  • LIOTHYRONINE6.75 ug/1

Pharmacologic classes

Thyroxine [CS]; Triiodothyronine [CS]; l-Thyroxine [EPC]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
73352-695-1073352069510100 TABLET in 1 BOTTLE (73352-695-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40fa228f-9bfc-fc71-e063-6394a90a9ab6

Use it

Look up 73352-695 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73352-695 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73352-695. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.